UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044673
Receipt number R000051020
Scientific Title Superior vena cava Appropriate isolation with Radiofrequency catheter ablation
Date of disclosure of the study information 2022/07/01
Last modified on 2021/06/27 15:30:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Superior vena cava Appropriate isolation with Radiofrequency catheter ablation

Acronym

SAPPORO-RFCA Study

Scientific Title

Superior vena cava Appropriate isolation with Radiofrequency catheter ablation

Scientific Title:Acronym

SAPPORO-RFCA Study

Region

Japan


Condition

Condition

Atrial fibrillation

Classification by specialty

Cardiology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study is aimed to establish the simplified and effective method for SVC isolation and to elucidate the property of the arrhythmogenic SVCs.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Establishment of the safe and effective SVC isolation method using the decremental property of arrhythmogenic SVCs

Key secondary outcomes

1. Area, decremental property and conduction velocity of SVCs with or without arrhythmogenesis. 2. Number and locations of breakthrough sites from the RA to SVC. 3. Excitation patterns at the RA-SVC junction during AF induction.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients undergoing catheter ablation for atrial fibrillation that requires the use of Pentaray and Lasso catheters for the treatment

Key exclusion criteria

Patients who were judged to be ineligible by a study investigator

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Hisashi
Middle name
Last name Yokoshiki

Organization

Sapporo City General Hospital

Division name

Cardiovascular Medicine

Zip code

060-8604

Address

Kita-11, Nishi-13, Chuo-ku, Sapporo 060-8604, Japan

TEL

011-726-2211

Email

hisashi.yokoshiki@doc.city.sapporo.jp


Public contact

Name of contact person

1st name Masahiro
Middle name
Last name Toba

Organization

Sapporo City General Hospital

Division name

Cardiovascular Medicine

Zip code

060-8604

Address

Kita-11, Nishi-13, Chuo-ku, Sapporo 060-8604, Japan

TEL

011-726-2211

Homepage URL

https://www.city.sapporo.jp/hospital/

Email

masahiro-toba@doc.city.sapporo.jp


Sponsor or person

Institute

Sapporo City General Hospital

Institute

Department

Personal name



Funding Source

Organization

Self-funding

Organization

Division

Category of Funding Organization

Local Government

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Sapporo City General Hospital Research Ethics Committee

Address

Kita-11, Nishi-13, Chuo-ku, Sapporo 060-8604, Japan

Tel

011-726-2211

Email

ho.shomu@city.sapporo.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2021 Year 06 Month 07 Day

Date of IRB

2021 Year 06 Month 10 Day

Anticipated trial start date

2021 Year 06 Month 14 Day

Last follow-up date

2024 Year 11 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The electrophysiological and anatomical characteristics of arrhythmogenic SVCs


Management information

Registered date

2021 Year 06 Month 27 Day

Last modified on

2021 Year 06 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051020


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name